Prot #CNTO1275ISD1001: Open-label Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of Ustekinumab in Pediatric Participants

Project: Research project

Project Details

StatusActive
Effective start/end date1/12/22 → 8/31/25

Funding

  • Janssen Research & Development, LLC (Prot #CNTO1275ISD1001)